Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
21.81
+0.41 (1.92%)
At close: Dec 5, 2025, 4:00 PM EST
22.24
+0.43 (1.97%)
After-hours: Dec 5, 2025, 6:16 PM EST
Enliven Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,294 | 1,099 | 570 | - | - | - |
| Market Cap Growth | 6.39% | 92.74% | - | - | - | - |
| Enterprise Value | 817 | 808 | 307 | - | - | - |
| Last Close Price | 21.81 | 22.50 | 13.84 | - | - | - |
| PB Ratio | 2.71 | 3.55 | 2.32 | - | - | - |
| P/TBV Ratio | 2.72 | 3.55 | 2.32 | - | - | - |
| Debt / Equity Ratio | 0.00 | - | 0.00 | 0.01 | 0.00 | 0.00 |
| Quick Ratio | 32.60 | 19.70 | 9.78 | 7.78 | 19.13 | 88.20 |
| Current Ratio | 32.95 | 19.99 | 10.28 | 8.00 | 19.24 | 88.35 |
| Return on Equity (ROE) | -25.43% | -32.04% | -44.90% | -41.90% | -20.94% | - |
| Return on Assets (ROA) | -17.62% | -21.87% | -28.94% | -24.66% | -12.67% | - |
| Return on Capital (ROIC) | -18.34% | -23.50% | -32.14% | -26.86% | -13.08% | - |
| Return on Capital Employed (ROCE) | -23.60% | -33.70% | -33.40% | -52.70% | -23.00% | -7.20% |
| Earnings Yield | -7.51% | -8.10% | -12.55% | - | - | - |
| FCF Yield | -5.55% | -6.66% | -10.77% | - | - | - |
| Buyback Yield / Dilution | -19.30% | -32.43% | -1037.74% | 60.02% | -56.70% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.